Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/390
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSuresh, T-
dc.contributor.authorSwamy, S K-
dc.contributor.authorReddy, V M-
dc.date.accessioned2008-03-18T10:48:57Z-
dc.date.available2008-03-18T10:48:57Z-
dc.date.issued2007-01-
dc.identifier.issn0376-4699-
dc.identifier.urihttp://hdl.handle.net/123456789/390-
dc.description115-121en_US
dc.description.abstractThirty five different 4-aryl-1-substituted 2,6-dimethyl-3, 5-bis-N-[(substituted) carbamoyl] 1,4-dihydropyridines have been prepared from a three component condensation reaction of N-(2-chlorophenyl)-acetoacetamide; an aromatic aldehyde and a primary amine under four different experimental conditions. Except for conventional, all the experimental conditions are simple, eco-friendly, economical, and the reactions are rapid and high yielding. All the compounds have been purified and characterized by their spectral and elemental analysis data. The methods employed have been compared in terms of yields, cost and simplicity. All the compounds have been tested for their acute toxicity, gross behavioural studies and screened for their bronchodilatory activity by standard methods.en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.relation.ispartofseriesInt.Cl.⁸ C07Den_US
dc.sourceIJC-B 46B(1) January 2007en_US
dc.subjectN-(2-Chlorophenyl)acetoacetamideen_US
dc.subject1,4-dihydropyridineen_US
dc.subjectpotassium tert-butoxideen_US
dc.subjecttrimethyl silyl iodideen_US
dc.subject1-n-butyl-3-methylimidazolium tetrafluoroborateen_US
dc.subjectbronchodilatory activityen_US
dc.titleSynthesis and bronchodilatory activity of new 4-aryl-3,5-bis(2-chlorophenyl)- carbamoyl-2,6-dimethyl-1,4- dihydropyridines & their 1-substituted analoguesen_US
dc.typeArticleen_US
Appears in Collections:IJC-B Vol.46B(01) [January 2007]

Files in This Item:
File Description SizeFormat 
IJCB 46B(1) (2007) 115-121.pdf142.17 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.